GWAS |
- Chronic lymphocytic leukemia (time to first treatment) ( 33510140)
- Hepcidin/ferritin ratio ( 27846281)
- Metabolite risk score for predicting weight gain ( 31560688)
- Myopia (pathological) ( 23049088)
- Normal facial asymmetry (angle of surface orientation score) ( 30631343)
- Obesity-related traits ( 23251661)
- Opioid dependence ( 31250797)
- Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) ( 29912962)
- Total body bone mineral density ( 29304378)
|
- Dilated cardiomyopathy ( 33677556)
- Dilated cardiomyopathy (MTAG) ( 33495596)
- Electrocardiogram morphology (amplitude at temporal datapoints) ( 32916098)
- Fractional shortening ( 29403010)
- Hypertrophic cardiomyopathy ( 33495596)
- Hypertrophic cardiomyopathy (MTAG) ( 33495596)
- IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis) ( 28878392)
- IgG digalactosylation phenotypes (multivariate analysis) ( 28878392)
- IgG disialylation phenotypes (multivariate analysis) ( 28878392)
- IgG fucosylation phenotypes (multivariate analysis) ( 28878392)
- IgG galactosylation phenotypes (multivariate analysis) ( 28878392)
- IgG glycosylation ( 23382691)
- IgG monogalactosylation phenotypes (multivariate analysis) ( 28878392)
- IgG N-glycosylation phenotypes (multivariate analysis) ( 28878392 32128391)
- IgG sialylation phenotypes (multivariate analysis) ( 28878392)
- Left ventricle wall thickness ( 33495596)
- Left ventricular end-systolic volume ( 33495596)
- Left ventricular global circumferential strain ( 33495596)
- Left ventricular global radial strain ( 33495596)
- Left ventricular mass to end-diastolic volume ratio ( 33495596)
- N-glycan levels ( 31163085)
|